Tenet Healthcare Corp (THC) |
|
|
|
Tenet Healthcare Corp Income Statement Quarterly
THC
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
|
5,066.00 |
5,082.00 |
5,021.00 |
|
Health Care Organization Revenue Gross |
|
- |
- |
- |
|
Total Revenue |
5,379.00 |
5,066.00 |
5,082.00 |
5,021.00 |
4,990.00 |
Health Care Organization, Medical Supplies and Drugs Expense |
- |
- |
- |
- |
- |
Gross
Profit |
5,379.00 |
5,066.00 |
5,082.00 |
5,021.00 |
4,990.00 |
Selling, Administration, Marketing |
2,315.00 |
2,288.00 |
2,285.00 |
2,258.00 |
2,306.00 |
Depriciation & Amortization |
216.00 |
224.00 |
213.00 |
217.00 |
213.00 |
Research & development |
- |
- |
- |
- |
- |
Restructuring |
19.00 |
14.00 |
10.00 |
4.00 |
20.00 |
Other operatinig exp. /-income |
2,052.00 |
1,924.00 |
1,954.00 |
1,931.00 |
1,787.00 |
Unusual Income/ -Expense |
- |
- |
- |
- |
- |
Restructuring Settlement Impairment Provisions And Acquisition Cost |
53.00 |
47.00 |
16.00 |
21.00 |
129.00 |
Net Gainon Sale Consolidation And Deconsolidation Of Facilities |
- |
- |
- |
- |
-1.00 |
Net Losses On Sale Consolidation And Deconsolidation Of Facilities |
- |
- |
- |
- |
-1.00 |
Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities |
-11.00 |
1.00 |
- |
-13.00 |
1.00 |
Total operating costs including COS |
4,644.00 |
4,498.00 |
4,478.00 |
4,418.00 |
4,454.00 |
Operating income/-loss
|
735.00 |
568.00 |
604.00 |
603.00 |
536.00 |
Other Deductions / - Income |
Interest expense |
227.00 |
227.00 |
226.00 |
221.00 |
219.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
227.00 |
227.00 |
226.00 |
221.00 |
219.00 |
Extinguishment of Debt |
-22.00 |
- |
11.00 |
- |
- |
Loss (Income) from Equity Method Investments |
- |
- |
- |
- |
- |
Sale of Business |
- |
- |
- |
- |
- |
Sale of Assets |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
11.00 |
-4.00 |
-6.00 |
2.00 |
-4.00 |
Total costs & expenses |
4,860.00 |
4,721.00 |
4,709.00 |
4,641.00 |
4,669.00 |
Income /-loss before income taxes |
519.00 |
345.00 |
373.00 |
380.00 |
321.00 |
Income taxes expenses/-benefit |
63.00 |
79.00 |
80.00 |
84.00 |
47.00 |
Income after income taxes |
456.00 |
266.00 |
293.00 |
296.00 |
274.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
456.00 |
266.00 |
293.00 |
296.00 |
274.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Discontinued Operation Restructuring Settlement And Impairment Provisions Before Income Tax |
- |
- |
- |
- |
- |
Disposal Group Including Discontinued Operation Litigation And Investigation Expense |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
456.00 |
266.00 |
293.00 |
296.00 |
274.00 |
Noncontrolling interests |
212.00 |
165.00 |
170.00 |
153.00 |
172.00 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
244.00 |
101.00 |
123.00 |
143.00 |
102.00 |
EBIT |
746.00 |
572.00 |
599.00 |
601.00 |
540.00 |
EBITD |
962.00 |
796.00 |
812.00 |
818.00 |
753.00 |
EBITDA |
969.00 |
803.00 |
821.00 |
827.00 |
763.00 |
Per
Share (GAAP Quarterly, in $) |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
Basic EPS (excl. extra
items) |
2.42 |
0.99 |
1.21 |
1.40 |
0.98 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
2.42 |
0.99 |
1.21 |
1.40 |
0.98 |
Basic shares outstanding (Mill.
of Units) |
100.96 |
101.54 |
101.77 |
102.29 |
104.52 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
2.42 |
0.94 |
1.15 |
1.32 |
0.91 |
Diluted average shares (Mill.
of Units) |
107.01 |
104.43 |
104.78 |
106.01 |
108.44 |
Dividend per share |
- |
- |
- |
- |
- |
|
|